Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Cornebarrieu – page 47

1 551 clinical trials in Cornebarrieu, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Cornebarrieu at a glance
1 551
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

1 551 trials in Cornebarrieu

Open in trial search

Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Binimetinib
  • Sponsor:Unicancer

Study on the Safety and Effects of Radiprodil for Children with GRIN-related Disorder

Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Radiprodil
  • Sponsor:Grin Therapeutics Inc.

Crohn's disease

Recruiting

Study Comparing Vedolizumab and Adalimumab for Crohn's Disease Patients Who No Longer Respond to Adalimumab

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Centre Hospitalier Universitaire De Saint Etienne

Neoplasm

Recruiting

Continued Cancer Treatment Study with Abiraterone, Ipatasertib, Tiragolumab, and Drug Combination for Patients from Previous Genentech/Roche Trials

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:F. Hoffmann-La Roche AG

Pneumonia

Recruiting

Study Comparing Amoxicillin and Amoxicillin/Clavulanic Acid for Treating Community-Acquired Pneumonia in Patients Aged 65 and Older

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Amoxicillin
  • Sponsor:Centre Hospitalier Universitaire De Nantes

Lymphangioma

Recruiting

Study on Alpelisib for Treating Lymphatic Malformations in Patients with PIK3CA Mutation

Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Crohn's disease

Recruiting

Study on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

Investigational
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on Abatacept for Rheumatoid Arthritis in Patients Responding to Initial TNF Inhibitor Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Centre Hospitalier Universitaire De Montpellier

Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Centre Hospitalier Universitaire De Nice

Study on Rituximab for Patients with Acute Myocardial Infarction

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Assistance Publique Hopitaux De Paris

Study on Azathioprine for Preventing Relapse in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD) After First Attack

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Azathioprine
  • Sponsor:Hospices Civils De Lyon

Other cities in France

The busiest research cities in the country

All 376 cities in France

Clinical research in Cornebarrieu

What the registry says about research in the country

01 Lung Cancer Research

Studies focusing on innovative treatments for non-small cell lung cancer, particularly evaluating immunotherapy combinations and targeted therapies for elderly patients.

  • Immunotherapy optimization
  • Elderly patient care protocols
  • Treatment effectiveness evaluation

Notable research includes novel approaches combining atezolizumab with traditional chemotherapy protocols.

02 Breast Cancer Studies

Comprehensive research on hormone-sensitive breast cancer, investigating optimized treatment durations and comparing therapeutic approaches for metastatic cases.

  • Hormone therapy optimization
  • Metastatic treatment strategies
  • Personalized therapy approaches

Research focuses on improving outcomes for patients with ER+ HER2- breast cancer variants.

03 Gastrointestinal Oncology

Advanced studies in colon carcinoma and biliary tract cancers, exploring both surgical and chemotherapy innovations.

  • Adjuvant treatment protocols
  • Neoadjuvant therapy assessment
  • Elderly patient care strategies

Including groundbreaking research on circulating tumor DNA for treatment decision-making.

04 Neurological Conditions

Innovative research in migraine management, exploring emergency interventions using advanced oxygen therapy techniques.

  • Emergency treatment protocols
  • High-flow oxygen therapy
  • Acute pain management

Focusing on rapid relief strategies in emergency department settings.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.